LEXINGTON, Mass.--(BUSINESS WIRE)--May 17, 2006--Predix Pharmaceuticals, which recently announced a definitive agreement to merge with EPIX Pharmaceuticals (NASDAQ: EPIX - News), announced today that Michael G. Kauffman, M.D., Ph.D., president and CEO of Predix, will participate in a Focus Session entitled “The Future of Neuropsychiatry and Specialty Pharmaceuticals” at The Neurotech Industry Investing & Business Conference at the Westin San Francisco Airport, Millbrae, California, on Thursday, May 18, 2006 at 1:30 p.m. (PDT).
